2026-01-27T16:35:13-06:00 2025-07-31 760722072 FOUMBERG JUNEJA ROCHER & CO PC 16311 VENTURA BLVD SUITE 1180 ENCINO CA 91436 990 2024-08-01 953901768 THE JOHN DOUGLAS FRENCH ALZHEIMER'S FOUNDATION JOHN 2132193575 1191 BROOKMERE RD PASADENA CA 91105 CHERYL MAE CRAFT PHD PRESIDENT AND CEO 2132193575 2026-01-20 1 1 MARK A LUCHT CPA P00112942 8189816100 2026-01-20 2024 2025-03-06 01:10:19Z CHERYL MAE CRAFT PHD 1191 BROOKMERE RD PASADENA CA 91105 274391 0 X WWW.JDFAF.ORG X 1983 CA PROVIDING SEED MONEY FOR PROMISING ALZHEIMER'S RESEARCH TO ASSIST IN THE PREVENTION, TREATMENT AND CURE OF ALZEIMER'S DISEASE. 9 8 0 9 0 0 523103 243759 0 0 -18733 30632 0 0 504370 274391 0 0 0 0 72000 72000 0 0 0 16824 14641 88824 86641 415546 187750 819774 1007524 0 0 819774 1007524 X THE JOHN DOUGLAS FRENCH ALZHEIMER'S FOUNDATION (JDFAF) PROVIDES CRITICAL SEED MONEY FOR NOVEL AND PROMISING ALZHEIMER'S RESEARCH, GENERALLY NOT FUNDED BY THE GOVERNMENT OR PHARMACEUTICALS TO ASSIST IN THE PREVENTION, TREATMENT AND CURE OF ALZHEIMER'S DISEASE. 0 0 36000 THE JOHN DOUGLAS FRENCH ALZHEIMER'S FOUNDATION (JDFAF) BOARD OF DIRECTORS DEVELOPED A FUTURE DIRECTION, LAYING OUT THE STRATEGIC IMPLEMENTATION OF A PLAN TO ENABLE JDFAF TO MOST EFFECTIVELY FULFILL ITS ORIGINAL MISSION TO ACCELERATE FINDING A CURE OR TREATMENT FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES, RECOGNIZING THE SIGNIFICANT HISTORY, CURRENT REALITIES AND NEW ADVANCES IN DRUG DISCOVERY AND POTENTIAL TREATMENTS. THE JDFAF BOARD OF DIRECTORS DECIDED THAT THE FUTURE IS NOW, AND JDFAF ESTABLISHED THIRTEEN ENDOWMENTS TO SUPPORT PROFESSORSHIPS ACROSS FOUR TOP UNIVERSITIES IN CALIFORNIA AND CREATED A COMPREHENSIVE CONSORTIUM FOR ALZHEIMER'S DISEASE WITH AN ENDOWMENT TO HOST AN ANNUAL MEETING. JDFAF IS GRATEFUL TO CONTINUE TO RECEIVE GENEROUS DONATIONS FROM (CONTINUED ON SCH. O) ESTATES, TRUSTS, AND INDIVIDUALS; HOWEVER, WITHIN THE NEXT TWO YEARS, WE ANTICIPATE THE MAJORITY OF THE REMAINING FUNDS WILL BE DONATED TO ACCELERATE JDFAF'S MISSION. 36000 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 CA X CHERYL MAE CRAFT PHD 2132193575 1191 BROOKMERE RD PASADENA CA 91105 CHERYL MAE CRAFT PDH PRESIDENT AND CEO 20.00 0.00 X X 60000 0 0 ROBERT ABERNETHY DIRECTOR 0.10 0.00 X 0 0 0 MARGARET E BLACK VICE PRESIDENT 1.00 0.00 X X 0 0 0 KAREN BEDROSIAN COYNE DIRECTOR 0.10 0.00 X 0 0 0 BRENDA KLEHN DIRECTOR 0.10 0.00 X 0 0 0 BJ KIRWAN HANNA TO 052025 CHAIRMAN 1.00 0.00 X X 0 0 0 GENEVIEVE MCSWEENEY SECRETARY 1.00 0.00 X X 0 0 0 KATHLEEN TAGGARES DIRECTOR 0.10 0.00 X 0 0 0 EUGENE ST JOHN DIRECTOR 0.10 0.00 X 0 0 0 ALLISON THOMSEN TREASURER 1.00 0.00 X X 0 0 0 BRUCE L MILLER MD MEDICAL DIRECTOR (EX. OFFICIO) 1.00 0.00 X 12000 0 0 72000 0 0 0 0 0 0 0 243759 243759 30632 30632 274391 0 0 30632 72000 36000 36000 758 758 7120 7120 2276 2276 1227 1227 3134 3134 BANK SERVICE CHARGES 126 126 86641 36000 50641 0 269774 176910 550000 830614 72249 72249 0 0 819774 1007524 0 0 X 819774 1007524 0 0 819774 1007524 819774 1007524 187750 0 X 0 0 0 X 471435 686116 183298 523103 243759 2107711 471435 686116 183298 523103 243759 2107711 1509653 598058 30151 35728 58416 6085 30632 161012 2268723 0.26360 0.25310 X FACTS AND CIRCUMSTANCES TEST THE FOLLOWING FACTS DEMONSTRATE THAT THE JOHN DOUGLAS FRENCH ALZHEIMER'S FOUNDATION (JDFAF) SATISFIES THE FACTS AND CIRCUMSTANCES TEST OF REGULATION S1.170A-9(F)(3) AND QUALIFIES AS A PUBLIC CHARITY UNDER 509(A)(1) AND S170(B)(1)(A)(VI): - 10% OF SUPPORT LIMITATION: THE ORGANIZATION'S PUBLIC SUPPORT IS IN EXCESS OF THE 10% REQUIREMENT, QUALIFYING IT UNDER THE FACTS-AND-CIRCUMSTANCES TEST. - ATTRACTION OF PUBLIC SUPPORT: THE ORGANIZATION HAS PURSUED, SINCE ITS INCEPTION, A FUNDRAISING PROGRAM THAT RELIES ON GRANTS FROM ESTATES, TRUSTS, AND INDIVIDUALS, AS WELL AS OTHERS. THE JDFAF BOARD OF DIRECTORS DEVELOPED A PLAN TO MOST EFFECTIVELY FULFILL THE ORGANIZATION'S ORIGINAL MISSION - TO ACCELERATE FINDING A CURE OR TREATMENT FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES - RECOGNIZING THE SIGNIFICANT HISTORY, CURRENT REALITIES AND NEW ADVANCES IN DRUG DISCOVERY AND POTENTIAL TREATMENTS. IN 2018, THE JDFAF BOARD OF DIRECTORS DECIDED TO ACCELERATE THE ORGANIZATION'S ORIGINAL MISSION AND ESTABLISHED AT LEAST TEN ENDOWMENTS TO SUPPORT PROFESSORSHIPS AND RESEARCH PROGRAMS ACROSS FOUR PRESTIGIOUS UNIVERSITIES IN CALIFORNIA AND CREATED A COMPREHENSIVE CONSORTIUM WITH AN ENDOWMENT TO HOST AN ANNUAL MEETING WITH CONTINUED OVERSIGHT FROM THE JDFAF EXECUTIVE BOARD. ALL OF THE ORGANIZATION'S FUNDS WILL BE DONATED WITHIN THE NEXT THREE YEARS. THE ORGANIZATION WILL CONTINUE TO RECEIVE DONATIONS DURING THIS TIME; HOWEVER, JDFAF ANTICIPATES SOME DECLINE IN PUBLIC SUPPORT. - PERCENTAGE OF FINANCIAL SUPPORT: THE PUBLIC SUPPORT IS IN EXCESS OF THE 10% FLOOR, BUT WITHIN OF 8.00% AND 9.86% OF THE 33.34% WHICH WOULD HAVE MADE THE FACTS-AND-CIRCUMSTANCES DISCUSSION UNNECESSARY FOR THE LAST TWO FISCAL YEARS RESPECTIVELY. - SOURCES OF SUPPORT: SINCE ITS INCEPTION, THE JDFAF HAS ATTRACTED A BROAD RANGE OF SUPPORT FROM UNRELATED DONORS INCLUDING ESTATES, TRUSTS, INDIVIDUALS, OTHER FOUNDATIONS, AND OTHERS. AS STATED ABOVE, THE ORGANIZATION WILL CONTINUE TO RECEIVE THESE DONATIONS DURING THE STRATEGIC IMPLEMENTATION OF THE PLAN TO MOST EFFECTIVELY FULFILL ITS ORIGINAL MISSION WITHIN THE NEXT THREE YEARS. - GOVERNING BODY: JDFAF'S BOARD OF DIRECTORS REPRESENT THE BROAD INTERESTS OF THE PUBLIC. THE ORGANIZATION'S EXECUTIVE BOARD OVERSIGHT COMMITTEE IS LED BY JDFAF'S MEDICAL DIRECTOR, BRUCE MILLER, MD, AND JDFAF'S PRESIDENT AND CEO, CHERYL MAE CRAFT, PH.D. THIS COMMITTEE OVERSEES THE ABOVE-MENTIONED ENDOWMENTS TO CONFIRM THE FUNDS ARE BEING USED IN ACCORDANCE WITH THE GIFT AGREEMENTS. - AVAILABILITY OF PUBLIC FACILITIES OR SERVICES: THE PROGRAMS DESCRIBED ON THE ORGANIZATION'S FORM 990, THE JDFAF WEBSITE (HTTP://WWW.JDFAF.ORG), AND THE MISSION DESCRIBED ABOVE ARE SUBSTANTIALLY THE REASONS WHY THE ORGANIZATION CONTINUES TO ATTRACT SUPPORT. ADDITIONLALY, THE JDFAF'S WEBSITE HAS A DONATION LINK TO COLLECT CONTRIBUTIONS. ALL OF THE WORK DONE BY THE ORGANIZATION HAS THE GENERAL PUBLIC IN MIND AND FOCUSES ON THE ACCELERATION OF A CURE OR TREATMENT FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES. CONCLUSION: BASED ON THE FOREGOING, THE JOHN DOUGLAS FRENCH ALZHEIMER'S FOUNDATION SATISFIES THE FACTS-AND-CIRCUMSTANCES TEST AND QUALIFIES AS A PUBLIC CHARITY. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 72249 72249 0 0 FORM 990, PART VI, SECTION B, LINE 11B AFTER THE CPA FIRM PREPARES AND REVIEWS THE RETURN, IT IS SENT TO THE PRESIDENT, VICE PRESIDENT AND TREASURER FOR REVIEW AND EDITS. AFTER EDITS (IF ANY) ARE COMPLETE, A FINAL REVIEW IS CONDUCTED BY THE PRESIDENT, VICE PRESIDENT AND TREASURER BEFORE THE RETURN IS CIRCULATED TO ALL MEMBERS OF THE GOVERNING BODY AND FINALIZED. FORM 990, PART VI, SECTION B, LINE 12C ANY TRANSACTION WHICH MAY BE PERCEIVED AS AT ODDS WITH THE INTERESTS OF THE FOUNDATION ARE DISCUSSED BY THE FOUNDATION'S BOARD. ISSUES ARE REVIEWED AND RESOLVED BY THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 RELEVANT DOCUMENTS ARE MADE AVAILABLE UPON REQUEST.